From the, Centre for Alcohol Policy and Research (CAPR), (KE, CJCW, ML, EK), La Trobe University, Melbourne, Vic., Australia.
Burnet Institute, (CJCW), Melbourne, Vic., Australia.
Alcohol Clin Exp Res. 2020 Oct;44(10):1918-1932. doi: 10.1111/acer.14432. Epub 2020 Oct 3.
Research on alcohol consumption mostly relies on self-reported data, which are subject to recall bias. Wearable transdermal alcohol concentration (TAC) monitors address this limitation by continuously measuring the ethanol excreted via the skin. This systematic review aims to provide an overview of TAC monitors' reliability to detect alcohol consumption and methods to estimate breath alcohol concentration (BrAC) and number of standard drinks consumed in a given time frame.
The databases MEDLINE, PsycINFO, SCOPUS, Engineering Village, and CINAHL were systematically searched to identify 1,048 empirical research papers published from 2013 onwards, of which 13 were included after full-text screening. The selected studies included 3 TAC monitors: SCRAM™, WristTAS™, and Skyn™.
TAC measures of SCRAM, WrisTAS, and Skyn are found to be positively correlated with BrAC (r = 0.56 to 0.79) and/or self-reports (r = 0.62). Using the AMS criteria for detection results in low sensitivity, adjusted criteria can increase the sensitivity of the SCRAM from 39.9 to 68.5%. The WrisTAS and an early prototype of the Skyn showed high failure rates (17 to 38%). Recent advances toward transforming the TAC data into more clinically relevant measures have led to the development of mathematical models and the BrAC Estimator Software. Using TAC data, both approaches produce estimates explaining 70 to 82% of actual BrAC and self-reported drinking or to highly correlate with the actual BrAC measures (β = 0.90 to 0.91).
Transdermal alcohol monitors offer an opportunity to measure alcohol consumption in a valid and continuous way with mathematical models and software estimating BrAC values improving interpretation of TAC data. However, the SCRAM seems unable to detect low-to-moderate drinking levels using the thresholds and criteria set by the manufacturer. Moreover, the WrisTAS and the Skyn prototype show a high failure rate, raising questions about reliability. Future studies will assess the validity of new-generation wristbands, including the next Skyn generations.
关于酒精消费的研究主要依赖于自我报告的数据,这些数据容易受到回忆偏差的影响。可穿戴式经皮酒精浓度(TAC)监测器通过连续测量皮肤排出的乙醇来解决这一局限性。本系统综述旨在概述 TAC 监测器在检测酒精摄入方面的可靠性,以及在给定时间内估计呼气酒精浓度(BrAC)和饮用标准饮品数量的方法。
系统检索了 MEDLINE、PsycINFO、SCOPUS、Engineering Village 和 CINAHL 数据库,以确定 2013 年以来发表的 1,048 篇实证研究论文,经过全文筛选后,有 13 篇被纳入。所选研究包括 3 种 TAC 监测器:SCRAM™、WristTAS™和 Skyn™。
SCRAM、WrisTAS 和 Skyn 的 TAC 测量值与 BrAC(r=0.56 至 0.79)和/或自我报告呈正相关(r=0.62)。使用 AMS 检测结果的标准会导致灵敏度较低,调整标准可以将 SCRAM 的灵敏度从 39.9%提高到 68.5%。WrisTAS 和早期的 Skyn 原型显示出较高的失败率(17%至 38%)。将 TAC 数据转化为更具临床相关性的措施的最新进展导致了数学模型和 BrAC 估算软件的发展。使用 TAC 数据,这两种方法都可以产生解释 70%至 82%实际 BrAC 和自我报告饮酒的估计值,或者与实际 BrAC 测量值高度相关(β=0.90 至 0.91)。
经皮酒精监测器提供了一种以有效和连续的方式测量酒精摄入的机会,数学模型和软件估计 BrAC 值可提高 TAC 数据的解释性。然而,SCRAM 似乎无法使用制造商设定的阈值和标准来检测低至中度饮酒水平。此外,WrisTAS 和 Skyn 原型的失败率较高,这引发了对可靠性的质疑。未来的研究将评估新一代腕带的有效性,包括下一代 Skyn 腕带。